Your browser doesn't support javascript.
loading
Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
Barry, Michael J; Nicholson, Wanda K; Silverstein, Michael; Chelmow, David; Coker, Tumaini Rucker; Davis, Esa M; Donahue, Katrina E; Jaén, Carlos Roberto; Li, Li; Ogedegbe, Gbenga; Rao, Goutham; Ruiz, John M; Stevermer, James; Tsevat, Joel; Underwood, Sandra Millon.
Afiliação
  • Barry MJ; Harvard Medical School, Boston, Massachusetts.
  • Nicholson WK; George Washington University, Washington, DC.
  • Silverstein M; Brown University, Providence, Rhode Island.
  • Chelmow D; Virginia Commonwealth University, Richmond.
  • Coker TR; University of Washington, Seattle.
  • Davis EM; University of Maryland School of Medicine, Baltimore.
  • Donahue KE; University of North Carolina at Chapel Hill.
  • Jaén CR; The University of Texas Health Science Center, San Antonio.
  • Li L; University of Virginia, Charlottesville.
  • Ogedegbe G; New York University, New York, New York.
  • Rao G; Case Western Reserve University, Cleveland, Ohio.
  • Ruiz JM; University of Arizona, Tucson.
  • Stevermer J; University of Missouri, Columbia.
  • Tsevat J; The University of Texas Health Science Center, San Antonio.
  • Underwood SM; University of Wisconsin, Milwaukee.
JAMA ; 330(3): 253-260, 2023 07 18.
Article em En | MEDLINE | ID: mdl-37462699
Importance: Familial hypercholesterolemia and multifactorial dyslipidemia are 2 conditions that cause abnormally high lipid levels in children, which can lead to premature cardiovascular events (eg, myocardial infarction and stroke) and death in adulthood. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for lipid disorders in asymptomatic children and adolescents. Population: Asymptomatic children and adolescents 20 years or younger without a known diagnosis of a lipid disorder. Evidence Assessment: The USPSTF concludes that the current evidence is insufficient and the balance of benefits and harms for screening for lipid disorders in asymptomatic children and adolescents 20 years or younger cannot be determined. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Programas de Rastreamento / Dislipidemias Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Programas de Rastreamento / Dislipidemias Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article